Financial Consulate, Inc Bristol Myers Squibb CO Transaction History

Financial Consulate, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $13,799 - $15,651	210 Added 6.65%	3,370 $233,000
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $194,276 - $232,955	3,160 New	3,160 $231,000
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $187,095 - $219,158	-3,162 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $10,834 - $11,798	-175 Reduced 5.24%	3,162 $211,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $1,443 - $1,635	25 Added 0.75%	3,337 $207,000
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $19,813 - $21,955	-345 Reduced 9.43%	3,312 $200,000
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $6,852 - $8,011	-125 Reduced 3.31%	3,657 $215,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $835 - $1,213	-18 Reduced 0.47%	3,782 $211,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $186,998 - $243,922	3,800 New	3,800 $244,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.